|Bid||207.00 x 800|
|Ask||206.22 x 1200|
|Day's Range||204.58 - 206.95|
|52 Week Range||108.85 - 224.24|
|Beta (5Y Monthly)||0.28|
|PE Ratio (TTM)||44.22|
|Earnings Date||Jan 28, 2021 - Feb 01, 2021|
|Forward Dividend & Yield||1.56 (0.76%)|
|Ex-Dividend Date||Nov 10, 2020|
|1y Target Est||189.80|
Quest Diagnostics (DGX) is moving ahead in terms of its growth strategy, which consists of five elements.
Lower sales of Phibro's (PAHC) Performance Products arm's copper-based products raise concerns.
Tandem Diabetes' (TNDM) t:slim X2 Insulin Pump with Control-IQ Advanced Hybrid Closed-Loop Technology cleared for use in Canada post the receipt of Health Canada approval.